Quick Answer
BriaCell Therapeutics Corp. reported Stockholders Equity of -$3.78 million for the year ending 2023.
- BriaCell Therapeutics Corp. showed a decrease of -136.6% in Stockholders Equity from 2022 to 2023.
- This data is from BriaCell Therapeutics Corp.'s annual report (Form 10-K), filed with the SEC on October 25, 2023.
- XBRL data for this metric is available from 2020 to 2023 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2021: $1.58 million | Q1 2022: $16.43 million | Q2 2022: $9.96 million | Q4 2022: $10.33 million | Q1 2023: -$1.28 million | Q2 2023: -$5.89 million.
- Over the full 4 years of available data (2020 to 2023), BriaCell Therapeutics Corp.'s Stockholders Equity has declined by 37.8%.
- Historical annual values: Fiscal year 2023: -$3.78 million | Fiscal year 2022: $10.33 million | Fiscal year 2021: $27.67 million | Fiscal year 2020: -$2.74 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: